Home
Login | Register
  • Health & Wellness
  • Conditions
  • Insurance & Money
Home » Personal Health » Prescription Drugs

Prescription Drugs

Prescription Drugs:

Prescription Drugs, Online Prescription Drug Information, Articles on Prescription Medication, Cheap Prescription Plan Info

  • FDA To Reduce the Misuse of Medications
    Tyler Woods Ph.D.
    Nov 5th, 2009

    In an attempt to reduce the deaths and serious health problems caused by misuse of medication, the FDA is trying to identify the most serious threats and find ways to avoid them.

  • GERD Drugs May Cause Unexpected Side Effects
    Deborah Mitchell
    Nov 2nd, 2009

    Drugs used to treat GERD (gastroesophageal reflux) and laryngopharyngeal reflux (LPR) may cause unexpected side effects and complications, according to a new report published in Otolaryngology—Head and Neck Surgery. These additional adverse effects are in addition to the ones normally associated with use of proton pump inhibitors, which include headache, diarrhea, abdominal pain, dry mouth, constipation, nausea, rash, and flatulence.

  • FDA Is Not Following up on Unproven Drugs
    Tyler Woods Ph.D.
    Oct 26th, 2009

    Investigators have stated that the Food and Drug Administration (FDA) has permitted certain cancer drugs to stay on the market after follow-up studies demonstrated they didn't extend patients' lives.

  • FDA Approves Colcrys (Colchicine, USP) For Gout Flares Prevention
    Ramona Bates MD
    Oct 19th, 2009

    The US Food and Drug Administration (FDA) approved Colcrys (colchicine, USP) at the end of July 2009 for the treatment of acute gout flares when taken at the first sign of a flare. It has now been approved for prophylaxis (prevention) of gout flares.

  • FDA Delays Amgen's Denosumab Osteoporosis Drug
    Denise Reynolds RD
    Oct 19th, 2009

    The U.S. Food and Drug Administration has delayed approval for denosumab, a new medication for preventing post-menopausal osteoporosis. The regulatory agency is requesting a new clinical program and further information on the post-marketing surveillance program for the drug, which will bear the brand name Prolia. The FDA has also requested an update on all safety data related to denosumab.

  • Walmart Starts Home Delivery Program, Offers Tamiflu Compounding
    Denise Reynolds RD
    Oct 18th, 2009

    Walmart.com announced this week that it has launched a wide assortment of top-selling personal care products, including health and beauty items and some over-the-counter medications that will be available for home delivery.

  • FDA, State Websites Explain Medication Disposal
    Deborah Mitchell
    Oct 17th, 2009

    How should you dispose of unneeded or expired medications? This question is answered by a variety of state websites and the Food and Drug Administration (FDA), which has just launched a web page for consumers on medication disposal. There is a difference between the FDA site and most state websites, so consumers may do well to consult their own state’s disposal options as well as those offered by the FDA.

  • FDA Sued by Allergan Over "Off-Label" Policy
    Ramona Bates MD
    Oct 2nd, 2009

    Yesterday, the company who makes BOTOX, Allergan, filed a lawsuit contending that the Government's legal position regarding active marketing to doctors for off-label use violates the First Amendment and is inconsistent with the Federal Food, Drug & Cosmetic Act.

  • Hong Kong Alerts Pharmaceutical Products Recall
    Ruzanna Harutyunyan
    Sep 29th, 2009

    Dragon Link (International) Trading Company Ltd, a licensed wholesaler of pharmaceutical products, is recalling products which were found to have contained manganese level in excess.

  • Human Genome drug Benlysta may cost $20,000 a year
    Jenny Decker RN
    Sep 29th, 2009

    Systemic lupus erythematosus is a very complicated disease. It affects the body’s immune system, involving the body’s organs, kidneys, brain, lungs, joints, blood, and skin. In fact, some experts believe that it may be as many as five different diseases, writes the Wall Street Journal. Lupus is difficult to treat because of the various signs and symptoms associated with the disorder. The company Human Genome has developed a drug called Benlysta. If this drug is approved by the FDA, it may cost patients $20,000 a year.

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
 
  • Privacy Policy
  • Disclaimer
  • About Us
  • Editorial Review Process
  • Advertise
  • Contact
  • Contributors
  • Health RSS Feeds
Copyright eMaxhealth.com 2005-2009. All rights reserved.